Literature DB >> 21489802

Synthesis of 4β-carbamoyl epipodophyllotoxins as potential antitumour agents.

Ahmed Kamal1, B Ashwini Kumar, Paidakula Suresh, Aarti Juvekar, Surekha Zingde.   

Abstract

A series of new 4β-carbamoyl epipodophyllotoxin analogues have been synthesized and evaluated for their anticancer activity against eleven cancer cell lines including Zr-75-1, MCF7, KB, Gurav, DWD, Colo 205, A-549, Hop62, PC3, SiHa and A-2780. Most of the compounds exhibited better growth-inhibition activities against tested cell lines than that of etoposide. Further, compounds 6g and 6i are also evaluated for their DNA topoisomerase-II (topo-II) inhibition activity and they exhibited significant inhibition of topo-II catalytic activity comparable to etoposide.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21489802     DOI: 10.1016/j.bmc.2011.03.030

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Toward synthesis of third-generation spin-labeled podophyllotoxin derivatives using isocyanide multicomponent reactions.

Authors:  Liang Kou; Mei-Juan Wang; Li-Ting Wang; Xiao-Bo Zhao; Xiang Nan; Liu Yang; Ying-Qian Liu; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Eur J Med Chem       Date:  2014-01-29       Impact factor: 6.514

Review 2.  Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.

Authors:  Ying-Qian Liu; Jing Tian; Keduo Qian; Xiao-Bo Zhao; Susan L Morris-Natschke; Liu Yang; Xiang Nan; Xuan Tian; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2014-05-14       Impact factor: 12.944

3.  Click chemistry-assisted synthesis of triazolo linked podophyllotoxin conjugates as tubulin polymerization inhibitors.

Authors:  M V P S Vishnuvardhan; Saidi Reddy V; Kunta Chandrasekhar; V Lakshma Nayak; Ibrahim Bin Sayeed; Abdullah Alarifi; Ahmed Kamal
Journal:  Medchemcomm       Date:  2017-07-18       Impact factor: 3.597

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.